COVID-19治療口服抗病毒藥品Molnupiravir 衛教單張

molnupiravir dose  Someone who stops breastfeeding in order to take molnupiravir may resume four days after receiving their last dose of the drug This gives the body enough time They received molnupiravir at a dosage of 800 mg twice daily for 5 days for mild-to-moderate COVID-19

Molnupiravir is a product that the FDA is allowing to be given for emergency use to treat COVID-19 It is used by adults 18 years of age and older who have days after the last dose of molnupiravir Drug Interactions1: No No dosage adjustment is required in patients with renal impairment, and no

Molnupiravir Generic name: molnupiravir Dosage form: oral capsule Drug class: Miscellaneous antivirals  No dose adjustment of LAGEVRIO is required in patients with renal impairment